Please assess the completion status of the following clinical trial:

Trial Title: Feeding Intolerance in Formula-Fed Infants

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~Inclusion Criteria for Stage 1:~* Singleton full term birth with birth weight of \> 2500g.~* Infant between 0 and 60 days of age.~* Discontinuation of medications that might affect gastrointestinal (GI) tolerance.~* Infant is exclusively formula-fed a full-lactose, intact cow milk protein-based infant formula (CMF) for less than 7 days prior to enrollment.~Inclusion Criteria for Stage 2:~* Infant was fed according to protocol in Stage 1 of the study.~* Infant was identified as being fussy using the Intolerance Assessment Tool in Stage 1.~Exclusion Criteria:~Exclusion Criteria for Stage 1:~* Chromosomal or major congenital anomalies.~* Suspected or known metabolic or physical diseases affecting infant feeding and/or metabolism.~* Hospitalization, other than for delivery, prior to enrollment.~* Severe uncontrolled eczema, visible bloody stools or milk protein allergy prior to enrollment.~* More than 1 substitution of an infant formula other than full-lactose, intact cow milk formula (CMF) since birth.~* Use of a prokinetic drug within 7 days before enrollment.~Exclusion Criteria for Stage 2:~* Infant's intolerance symptom was caused by another reason, for example known infection/illness, food allergy, or response to vaccination(s).~* Infant has immunization(s) within 3 days of enrollment in Stage 2.

- Gender: ALL
- Minimum Age: None
- Maximum Age: 60 Days
- Healthy Volunteers: t

Study Arms:
- Partially Hydrolyzed Infant Formula (Type: EXPERIMENTAL): Fed ad lib.

Based on this trial design, predict the completion outcome and termination type (if applicable).